IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
Stephen Dean Sharp & David John Hughes v GE Healthcare Bio-Sciences AB [2014] APO 10
Patent Application: 2005317279
Title:Purification of immunoglobulins
Patent Applicant: GE Healthcare Bio-Sciences AB
Opponent: Stephen Dean Sharp & David John Hughes
Delegate: Dr B. Akhurst
Decision Date: 19 February 2014
Hearing Date: 28 November 2013, in Canberra
Catchwords: PATENTS - section 59 opposition - no evidence in answer to the opposition or submissions from the applicant - inventive step - claims found to lack an inventive step in light of a prior art document cited in the application - manner of manufacture - not established that the claimed combination is obvious on the face of the specification - useful - on a proper construction the claimed invention is useful - clarity - the claims provide a workable standard suitable to the intended use - lack of clarity not established - fair basis -the claims need not be limited to the preferred embodiments - lack of fair basis not established.
Representation: Patent applicant: Did not attend the hearing
Opponent: Dr Peter Brown, Griffith Hack, Sydney
IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
Patent Application: 2005317279
Title:Purification of immunoglobulins
Patent Applicant: GE Healthcare Bio-Sciences AB
Date of Decision: 19 February 2014
DECISION
The opposition is successful. The invention of claims 1-2, 4-5 and 7-17 lacks an inventive step.
I believe it is possible to overcome the deficiencies I have identified by amendment of the specification. I therefore allow GE Healthcare Bio-Sciences AB two (2) months from the date of this decision to propose such amendments.
Costs are awarded according to Schedule 8 against GE Healthcare Bio-Sciences AB.
REASONS FOR DECISION
Background
Patent application 2005317279 was filed by GE Healthcare Bio-Sciences AB via the PCT on 12 December 2005 claiming priority from application SE 0403057-3 filed on 14 December 2004 and US 60/638,316 filed on 22 December 2004. The application entered national phase on 30 May 2007 and after examination was advertised as accepted on 24 February 2011.
Stephen Dean Sharp & David John Hughes filed a notice of opposition to grant of a patent on 24 May 2011 and served the statement of grounds and particulars on 24 August 2011. Evidence in support was completed on 24 April 2013 and consisted of a declaration by Robert L. Raison (the RLR declaration) with exhibits RLR-1 to RLR-11, and declarations by librarians Ngaine Ann Pettit-Young and Fiona Grigg.
No evidence was filed in answer to the opposition. On 30 August 2013 the applicant advised that it would not attend the hearing and that it wished the opposition to be determined on the basis of the evidence already before the Patent Office. The opponent was heard in Canberra on 28 November 2013.
Grounds of opposition
At the hearing, the grounds of opposition pressed by the opponent were manner of manufacture, inventive step, usefulness, clarity and fair basis.
Onus of Proof
The request for examination in this case was filed on 15 August 2007. Therefore, the substantive amendments to…
Keep reading for free
Create a free CaseChat account to read Stephen Dean Sharp & David John Hughes v GE Healthcare Bio-S... and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2014] APO 10
- Decision Date
CaseChat Overview and Summary
The key legal issues the court had to decide included whether the patent application met the criteria for inventive step, usefulness, clarity, and fair basis as required by the Australian Patents Act. The court examined the prior art and the specification to determine if the claimed invention was novel and non-obvious, useful, clearly defined, and fairly based on the disclosed matter.
The court found that claims 1-2, 4-5, and 7-17 of the patent application lacked an inventive step as they could be derived from the prior art, specifically US Patent US'990. The court determined that the person skilled in the art would have been directly led to the claimed invention as a matter of routine without any inventive effort. The court also found that the claimed invention was useful, clear, and fairly based on the specification. The court allowed GE Healthcare Bio-Sciences AB two months to amend the specification to overcome the identified deficiencies. Costs were awarded to the opponents according to Schedule 8.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.